Searched for
CML TREATMENT
Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...- Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its Bosutinib tablets. These tablets are used to treat certain ty...
- Alembic Pharmaceuticals gets USFDA nod for generic blood cancer treatment drugAlembic Pharmaceuticals has secured final approval from the USFDA for its generic Dasatinib tablets. These tablets are used to treat certai...
- Biocon shares up 3% after US FDA nod for key cancer drugsBiocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, en...
- Cipla shares in focus after U.S. FDA nod for Leukemia drugCipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...
- Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
- Alembic gets USFDA nod for cancer treatment drugDasatinib Tablet is indicated for the treatment of newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) i...
- Shilpa Medicare launches cancer drug at monthly therapy cost of Rs 6,440The drug substance patent on Dasatinib was owned by Bristol-Myers-Squibb and had expired on 12 April 12, 2020. The current monthly therapy ...
- Leprosy drug to treat cancer? Doctors hunt for new uses of old medicinesCDRI in Lucknow, scientists recently found that certain leprosy drugs might help treat myeloma, a type of blood cancer.
- MNCs deprive India of vital drugs despite getting monopoly rightsJapanese firm Otsuka Pharmaceuticals, Myers-Squibb, Novartis are deferring launch of medicines critical for treatment of serious non-commun...
- Pondicherry University team finds 7 new molecules to treat blood cancerCML is a type of blood cancer characterized by uncontrolled growth of white blood corpuscles (WBCs) in the bone marrow leading to imbalance...
- DIPP seeks details on blood cancer drug Dasatinib for issuance of compulsory licencesThe ministry has sought details from the Health Ministry, which had approached the DIPP for issuance of compulsory licences.
- Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MDToday’s Supreme Court judgment on the Glivec case means that innovator companies like Novartis will see little protection for intellectual ...
- Cancer drug Gleevec could damage heartGleevec, the pill that offered an easy way to target a difficult type of leukemia, may cause serious heart damage, researchers cautioned.
Load More
